<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We present a stochastic model of driver mutations in the transition from severe <z:hpo ids='HP_0005549'>congenital neutropenia</z:hpo> to <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> to <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The model has the form of a multitype branching process </plain></SENT>
<SENT sid="2" pm="."><plain>We derive equations for the distributions of the times to consecutive driver mutations and set up simulations involving a range of hypotheses regarding acceleration of the mutation rates in successive mutant clones </plain></SENT>
<SENT sid="3" pm="."><plain>Our model reproduces the clinical distribution of times at diagnosis of <z:e sem="disease" ids="C0280449" disease_type="Neoplastic Process" abbrv="">secondary AML</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Surprisingly, within the framework of our assumptions, stochasticity of the mutation process is incapable of explaining the spread of times at diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> in this case; it is necessary to additionally assume a wide spread of proliferative parameters among disease cases </plain></SENT>
<SENT sid="5" pm="."><plain>This finding is unexpected but generally consistent with the wide <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of characteristics of human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
</text></document>